Egyptian pharma EIPICO eyes EGP 800m investments over 3 years, excluding biosimilar project
Published 13 Jan,2021 via Daily News Egypt - A source has revealed that the Egyptian pharmaceutical company, EIPICO, plans to invest about EGP 800m over the next three years, directed towards re-modelling and renewing the machinery at its facilities. The financing will not be directed to its biosimilar project.
Continue reading
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Joined by 12,000+ Islamic economy professionals
Create a free account
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
Daily News Egypt